Medicine safety depends on reports made after approval too
Medicine safety depends on reports made after approval too
Updated at: November 2, 2026 at 01:12 AM
Approval is an important stage in a medicine's life, but safety monitoring continues afterward. MedSafetyWeek, running from November 2 to 8, 2026, draws attention to the information patients and health professionals can contribute after medicines enter everyday use.
WHO explains that clinical trials cannot identify every possible side effect. Monitoring continues throughout a medicine's life cycle, as people use it in circumstances that may differ from those represented in the original trials.
A suspected reaction need not appear immediately. Some symptoms develop after longer use, a change in dose or the use of several medicines together. WHO lists examples including skin rashes, stomach problems and changes in sleep or mood.
The campaign encourages reporting through national systems even when the cause is uncertain. A report records a suspicion. Combined with other reports and scientific evidence, it can help reveal a potential safety concern requiring further investigation.
New Zealand's regulator Medsafe offers a concrete example: people can submit suspected reactions through the CARM online form. It says anyone concerned about their health after a possible side effect should speak with a healthcare professional.
The wider message is participation. Patients, caregivers and professionals each see different parts of medicine use. Their reports help monitoring systems build knowledge over time, adding information that was unavailable when a treatment first received approval.
